Foghorn Therapeutics Inc. Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
Foghorn Therapeutics Inc. is a biotechnology research company headquartered in Watertown, Massachusetts. It focuses on discovering and developing medicines that exploit genetically determined dependencies within the chromatin regulatory system. The company uses a proprietary platform, Gene Traffic Control, to gain a mechanistic view of chromatin regulatory components and to identify and validate potential drug targets. Foghorn Therapeutics employs between 51 and 200 people. The company relocated its headquarters from Cambridge to Watertown in 2025 and reports revenue in the range of $25 million to $50 million with about $110 million in funding.